Patient Recruitment and Retention Services Market Scope
Patient recruitment and retention services offer informed and detailed planning, the commitment of adequate resources, careful monitoring, and timely identification and resolution of problems for a clinical study. Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. Strict procedures during clinical trials and drug development. Hence, the global patient recruitment and retention services market is slated to expand at a starry rate in the coming years.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Accelovance, Inc. (United States), Acurian, Inc. (United States), Bioclinica (United States), BMC Group (India), CROee, Inc (Japan), IQVIA (United States), Klick Inc. (Canada), Synexus Clinical Research Limited (United Kingdom), Syneos Health (United States) and WCCT Global (United States) |
CAGR | % |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.The Players having a strong hold in the market are Accelovance, Inc., Acurian, Inc., Bioclinica, and BMC Group. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Patient Recruitment and Retention Services market throughout the predicted period.
Accelovance, Inc. (United States), Acurian, Inc. (United States), Bioclinica (United States), BMC Group (India), CROee, Inc (Japan), IQVIA (United States), Klick Inc. (Canada), Synexus Clinical Research Limited (United Kingdom), Syneos Health (United States) and WCCT Global (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Patient Recruitment and Retention Services market by Type , by Application (Oncology, Infectious Diseases, Cardiovascular Diseases, CNS Disorders, Respiratory Disorders, Metabolic Disorders and Others) and Region with country level break-up.
On the basis of geography, the market of Patient Recruitment and Retention Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
On 27th March 2018, Accelovance, Inc., a global contract research organization (CRO) focusing on oncology, vaccines, and general medicine announced today that it has signed a merger agreement with Linical, a leading CRO based in Asia in the fields of oncology, immunology, and neurology.
On 3rd September 2020, ICON plc, a global provider of outsourced drug and government and public health organizations, has announced that it has launched Accellacare a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research in the US and MeDiNova Research in EMEA.
Influencing Trend:
Demand for Patient Recruitment and Retention Services is Increased in Outbreak of Pendamic COVID-19
Market Growth Drivers:
Increasing Awareness about Benefits of Clinical Trial and Reducing Time to Market for Medical Companies
Challenges:
Successful Recruitment of Patients is Major Challenging Aspects for Market
Restraints:
Clinical Trial is done on High Risk of Patients Life
Opportunities:
Increasing Healthcare Research and Development in Various Countries
Key Target Audience
Patient Recruitment and Retention Services Providers, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Other